PedAM
Pediatric Disease Annotations & Medicines
| Disease | lupus erythematosus, systemic |
| Phenotype | C0042373|vascular disease |
| Sentences | 23 |
| PubMedID- 20191526 | Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle). |
| PubMedID- 22126778 | Objective: to investigate the prevalence of cardiovascular diseases (cvd) in patients with systemic lupus erythematosus (sle) and estimate the associated risk factors for cvd. |
| PubMedID- 22210142 | Premature atherosclerotic cardiovascular disease in systemic lupus erythematosus: understanding management strategies. |
| PubMedID- 22957213 | vascular disease in systemic lupus erythematosus. |
| PubMedID- 25732129 | Methods: forty systemic lupus erythematosus women with cardiovascular disease (systemic lupus erythematosus cases), 40 systemic lupus erythematosus women without cardiovascular disease, and 40 healthy controls were enrolled in this study. |
| PubMedID- 24299152 | Altered levels of fxiia-serpin complexes in systemic lupus erythematosus (sle) patients with previous vascular disease (vd). |
| PubMedID- 25182169 | Prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross-sectional study of two cohorts. |
| PubMedID- 25638414 | Accelerated vascular disease in systemic lupus erythematosus: role of macrophage. |
| PubMedID- 24787906 | Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus. |
| PubMedID- 21360503 | Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. |
| PubMedID- 23942785 | Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. |
| PubMedID- 23612403 | [cerebrovascular disease in women with systemic lupus erythematosus]. |
| PubMedID- 22401784 | Subclinical vascular disease in patients with systemic lupus erythematosus: the additive deleterious effect of the antiphospholipid syndrome. |
| PubMedID- 23052654 | Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus. |
| PubMedID- PMC3467499 | Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle). |
| PubMedID- 24658835 | Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment. |
| PubMedID- 24470118 | 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort. |
| PubMedID- 25379191 | Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus. |
| PubMedID- 22174200 | Association between depression and vascular disease in systemic lupus erythematosus. |
| PubMedID- 24452079 | A rare form of vascular disease in systemic lupus erythematosus (sle), lupus vasculopathy is characterized by necrosis and accumulation of immunoglobulins (igs) and complements in the wall of arterioles and small arteries resulting in luminal narrowing. |
| PubMedID- 23886740 | Background and purpose: antiphospholipid syndrome may affect the incidence and pathogenesis of cerebrovascular diseases in patients with systemic lupus erythematosus. |
| PubMedID- 26354963 | Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients. |
| PubMedID- 24790989 | Imbalance between endothelial damage and repair: a gateway to cardiovascular disease in systemic lupus erythematosus. |
Page: 1